Multiomics analysis reveals that GLS and GLS2 differentially modulate the clinical outcomes of cancer
| dc.contributor.author | Saha, Subbroto Kumar | |
| dc.contributor.author | Riazul Islam, S. M. | |
| dc.contributor.author | Abdullah-Al-Wadud, M. | |
| dc.contributor.author | Islam, Saiful | |
| dc.contributor.author | Ali, Farman | |
| dc.contributor.author | Park, Kyoung Sik | |
| dc.contributor.institution | University of Aberdeen.Computing Science | en |
| dc.date.accessioned | 2024-05-06T14:21:00Z | |
| dc.date.available | 2024-05-06T14:21:00Z | |
| dc.date.issued | 2019-03-13 | |
| dc.description | Acknowledgements: This work was supported by the Deanship of Scientific Research at King Saud University through Research Group Grant RGP-1438-044. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 28 | |
| dc.format.extent | 5081768 | |
| dc.identifier | 281145544 | |
| dc.identifier | 6265bd35-f466-44bc-a8cc-fb46e4066e6e | |
| dc.identifier | 85075304743 | |
| dc.identifier.citation | Saha, S K, Riazul Islam, S M, Abdullah-Al-Wadud, M, Islam, S, Ali, F & Park, K S 2019, 'Multiomics analysis reveals that GLS and GLS2 differentially modulate the clinical outcomes of cancer', Journal of Clinical Medicine, vol. 8, no. 3, 355. https://doi.org/10.3390/jcm8030355 | en |
| dc.identifier.doi | 10.3390/jcm8030355 | |
| dc.identifier.iss | 3 | en |
| dc.identifier.issn | 2077-0383 | |
| dc.identifier.other | ORCID: /0000-0003-2968-9561/work/142570805 | |
| dc.identifier.uri | https://hdl.handle.net/2164/23409 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85075304743&partnerID=8YFLogxK | en |
| dc.identifier.vol | 8 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Journal of Clinical Medicine | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | Cancer therapy | en |
| dc.subject | Clinical outcomes | en |
| dc.subject | GLS | en |
| dc.subject | GLS2 | en |
| dc.subject | Glutaminase | en |
| dc.subject | Multiomics | en |
| dc.subject | Prognostic biomarkers | en |
| dc.subject | R Medicine | en |
| dc.subject | General Medicine | en |
| dc.subject | Supplementary Data | en |
| dc.subject | http://www.mdpi.com/2077-0383/8/3/355/s1 | en |
| dc.subject.lcc | R | en |
| dc.title | Multiomics analysis reveals that GLS and GLS2 differentially modulate the clinical outcomes of cancer | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Saha_etal_JCM_Multiomics_analysis_reveals_VOR_.pdf
- Size:
- 4.85 MB
- Format:
- Adobe Portable Document Format
